Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bentley Pharmaceuticals to Release Financial Results On Tuesday, April 30, 2002 and Hold Conference Call On Wednesday, May 1, 2002.


Business Editors & Health/Medical Writers

NORTH HAMPTON North Hampton is the name of several places in the United States:
  • North Hampton, Illinois
  • North Hampton, New Hampshire
  • North Hampton, Ohio
See also Northampton (disambiguation).
, N.H.--(BUSINESS WIRE)--April 25, 2002

Bentley Pharmaceuticals, Inc. (AMEX AMEX

See: American Stock Exchange
: BNT BNT Bentley Pharmaceuticals, Inc. (stock symbol)
BNT Boston Naming Test (psychology)
BNT Bermuda National Trust
BNT Bulgarian National TV
BNT Broadband Network Termination
BNT Binary File Transfer
), a specialty pharmaceutical company focused on advanced drug-delivery technologies, which also manufactures and markets generic and branded products in Europe, will release its first quarter financial results after the close of the market on Tuesday, April 30, 2002.

A conference call will be held on Wednesday, May 1, 2002 at 8:30 A.M. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
 to discuss the results.

Those who wish to participate in the conference call may telephone (888) 335-6674 fifteen minutes before the 8:30 A.M. starting time Noun 1. starting time - the time at which something is supposed to begin; "they got an early start"; "she knew from the get-go that he was the man for her"
commencement, get-go, offset, outset, showtime, start, kickoff, beginning, first
. A replay will be available by telephone for 30 days following the completion of the live call, at (877) 519-4471 toll free in the U.S. or (973) 341-3080 for international callers, PIN # 3250655.

Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures and markets a growing portfolio of generic and branded pharmaceuticals in Spain for the treatment of cardiovascular, gastrointestinal, infectious and neurological diseases through its subsidiaries Laboratorios Belmac and Laboratorios Davur.

Copies of the company's press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and  of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with identifying suitable drugs for drug delivery technologies, expanding generic and branded drug operations, development and commercialization of our products, relationships with our strategic partners, uncertainty of clinical trials, regulatory approval process, product sales concentration, unpredictability of patent protection, technological changes, the effect of economic conditions and other uncertainties detailed in Bentley's filings with the Securities and Exchange Commission.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 25, 2002
Words:319
Previous Article:Veritas DGC Inc. Announces Launch of Veritas Vantage.
Next Article:Eastman Announces 1st Quarter Earnings in Line with Earlier Guidance.
Topics:



Related Articles
Bentley Pharmaceuticals Will Release Financial Results, Hold Conference Call On March 21, 2001.
Bentley Pharmaceuticals Will Release Financial Results, Hold Conference Call On May 2, 2001.
Bentley Pharmaceuticals Will Release Financial Results, Hold Conference Call On August 1, 2001.
Bentley Pharmaceuticals Will Release Financial Results, Hold Conference Call On October 30, 2001.
Bentley Pharmaceuticals Will Release Financial Results, Hold Conference Call On October 30, 2001 At 11:00 A.M.
Bentley Pharmaceuticals Will Release Financial Results, Hold Conference Call On Wednesday, February 13, 2002 At 8:30 A.M.
Syncor to Announce First Quarter Earnings On April 24, 2002.
Bentley Pharmaceuticals Reports First Quarter Profitability On 62% Revenue Growth.
Bentley Pharmaceuticals to Present At UBS Warburg Conference.
Bentley Pharmaceuticals Reports Second Quarter Profitability On 65% Revenue Growth; Second Quarter Revenue Reaches a Record $10.1 Million.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles